RxDoctor Payments Data

Ping Xu

Adult Health · Uniontown, OHNPI 1255885216

Payments from drug & device makers

$1,167in general payments, 2019–2025

Across 66 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$245
  • Averitas Pharma Inc.$198
  • Globus Medical$130
  • Scilex Pharmaceuticals Inc.$126
  • Boston Scientific$114
  • AbbVie$93
  • plus $260 from 10 others

What the payments were for

  • Food & beverage$1,14298%
  • Education$242%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,167 in reported general payments places this provider in the 70th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$13,312
Medicare patients
19
Services billed
3,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,541$37,787
Buprenorphine143$33,358
OxycontinOxycodone Hcl51$25,634
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen879$20,352
Lidocaine157$11,729
LinzessLinaclotide19$10,344
BelbucaBuprenorphine Hcl18$8,904
Gabapentin680$8,463
Xtampza ErOxycodone Myristate11$8,380
ButransBuprenorphine18$7,921
Pregabalin399$7,733
MovantikNaloxegol Oxalate18$7,558
Tizanidine Hcl486$6,038
Morphine Sulfate ErMorphine Sulfate169$4,840
Diclofenac Sodium145$4,558

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone$19$33,579154 claims
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$245$17,28429 claims
AbbVieLinzess$93$10,34419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,184 adult health providers in Ohio.

Other adult health in Uniontown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →